InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Surrozen, Inc.

SRZN Clue Score17
United States Fiscal year ends December CIK 0001824893 Results filed 20 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
TCG Crossover GP II, LLC
22 Jul 2026
10% owner
Sell indirect
162,500
$21.25
$3.45M
TCG Crossover GP II, LLC
22 Jul 2026
10% owner
Sell indirect
162,500
$21.25
$3.45M
Craig C Parker
4 May 2026
Chief Executive Officer
Sell
4,524
$33.33
$150.80K
Charles O Williams
4 May 2026
Chief Operating Officer
Sell
2,036
$33.33
$67.87K
Yang Li
4 May 2026
Exec. Vice President, Research
Sell
1,584
$33.33
$52.80K
Charles O Williams
5 Jan 2026
Chief Operating Officer
Sell
1,566
$19.87
$31.11K
Yang Li
5 Jan 2026
Exec. Vice President, Research
Sell
1,118
$19.87
$22.21K
Charles O Williams
3 Jan 2025
CFO and COO
Sell
1,181
$17.37
$20.51K
Yang Li
3 Jan 2025
Exec. Vice President, Research
Sell
843
$17.37
$14.64K
Mitchell J Md Blutt
14 Dec 2022
10% owner
Sell indirect
1,885,000
—
no price
Mitchell J Md Blutt
14 Dec 2022
10% owner
Sell indirect
450,827
—
no price
Mitchell J Md Blutt
14 Dec 2022
10% owner
Sell indirect
1,297,922
—
no price
Mitchell J Md Blutt
14 Dec 2022
10% owner
Sell indirect
1,748,750
—
no price
Show all 95 transactions →

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 17
Shares from compensation/vesting 21,439,126
Sales filed before the plan box existed 4
History held since 25 Nov 2020